These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8028191)

  • 1. [Animal models for intractable hematologic disorders].
    Ikehara S
    Rinsho Ketsueki; 1994 May; 35(5):446-53. PubMed ID: 8028191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new bone marrow transplantation method for stem cell disorders.
    Ikehara S
    Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases.
    Ikehara S
    J Autoimmun; 2008 May; 30(3):108-15. PubMed ID: 18249091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation for autoimmune diseases.
    Brooks PM
    J Rheumatol Suppl; 1997 May; 48():19-22. PubMed ID: 9150113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases.
    Marmont AM
    J Rheumatol Suppl; 1997 May; 48():13-8. PubMed ID: 9150112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases.
    van Bekkum DW
    J Leukoc Biol; 2002 Oct; 72(4):609-20. PubMed ID: 12377928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
    Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
    J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell transplantation for autoimmune disorders. Preclinical experiments.
    van Bekkum DW
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):201-22. PubMed ID: 15302335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell therapy for treatment of autoimmune diseases.
    Van Bekkum DW
    Exp Hematol; 1998 Aug; 26(9):831-4. PubMed ID: 9694503
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantation.
    Van Bekkum DW
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S37-9. PubMed ID: 12931239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities.
    Good RA; Verjee T
    Biol Blood Marrow Transplant; 2001; 7(3):123-35. PubMed ID: 11302546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders.
    Ikehara S
    Ann N Y Acad Sci; 2005 Jun; 1051():626-34. PubMed ID: 16127003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct qualitative differences between normal and abnormal hemopoietic stem cells in vivo and in vitro.
    Kawamura M; Hisha H; Li Y; Fukuhara S; Ikehara S
    Stem Cells; 1997; 15(1):56-62. PubMed ID: 9007223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-dose chemotherapy followed by hematopoietic stem cell transplantation as therapy for systemic rheumatic autoimmune diseases].
    van den Hoogen FH; Schattenberg AV; Breedveld FC; Fibbe WE; van de Putte LB
    Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2061-5. PubMed ID: 9550764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical investigations that subserve efforts to employ bone marrow transplantation for rheumatoid or autoimmune diseases.
    Good RA; Ikehara S
    J Rheumatol Suppl; 1997 May; 48():5-12. PubMed ID: 9150111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress in chimerism and donor-specific tolerance.
    Jankowski RA; Ildstad ST
    Transplant Proc; 1996 Aug; 28(4):2071-4. PubMed ID: 8769159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunoablation or otherwise followed by hematopoietic cell stem as intensive treatment of severe autoimmune diseases].
    du Haut Champ AM
    Ann Ital Med Int; 2002; 17(1):11-20. PubMed ID: 11975110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new concept of stem cell disorders and their new therapy.
    Ikehara S
    J Hematother Stem Cell Res; 2003 Dec; 12(6):643-53. PubMed ID: 14977474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.